We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
Cap. Flow
+$263M
Cap. Flow %
4.63%
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$35.7M
2
MRK icon
Merck
MRK
+$30.3M
3
MSFT icon
Microsoft
MSFT
+$22.4M
4
YUMC icon
Yum China
YUMC
+$17.6M
5
OXY icon
Occidental Petroleum
OXY
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Financials 17.92%
3 Industrials 13.48%
4 Consumer Discretionary 11.28%
5 Healthcare 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTLA
1101
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-6,950
Closed -$376K
RTN
1102
DELISTED
Raytheon Company
RTN
-11,070
Closed -$2.06M
PIR
1103
DELISTED
Pier 1 Imports, Inc.
PIR
-1,300
Closed -$109K
DEST
1104
DELISTED
Destination Maternity Corporation
DEST
-14,018
Closed -$23K
PCMI
1105
DELISTED
PCM, Inc
PCMI
-28,658
Closed -$401K
LLL
1106
DELISTED
L3 Technologies, Inc.
LLL
-1,739
Closed -$328K
INSY
1107
DELISTED
Insys Therapeutics, Inc.
INSY
-14,640
Closed -$130K
BMS
1108
DELISTED
Bemis
BMS
-31,730
Closed -$1.45M
TVPT
1109
DELISTED
Travelport Worldwide Limited
TVPT
-26,239
Closed -$412K
TFCFA
1110
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
-649,577
Closed -$17.1M
FCB
1111
DELISTED
FCB Financial Holdings, Inc.
FCB
-18,210
Closed -$880K
AET
1112
DELISTED
Aetna Inc
AET
-22,900
Closed -$3.64M
PRSS
1113
DELISTED
CafePress Inc.
PRSS
-34,266
Closed -$62K
PNK
1114
DELISTED
Pinnacle Entertainment Inc.
PNK
-118,270
Closed -$2.52M
SYNT
1115
DELISTED
Syntel Inc
SYNT
-27,200
Closed -$534K
SIGM
1116
DELISTED
Sigma Designs Inc
SIGM
-355,925
Closed -$2.24M
CPLA
1117
DELISTED
Capella Education Company
CPLA
-16,520
Closed -$1.16M
GNRT
1118
DELISTED
Gener8 Maritime, Inc.
GNRT
-35,300
Closed -$159K
HDNG
1119
DELISTED
Hardinge Inc
HDNG
-13,812
Closed -$211K
BBRG
1120
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
-26,294
Closed -$60K
IPXL
1121
DELISTED
Impax Laboratories, Inc.
IPXL
-250,724
Closed -$5.09M
BIVV
1122
DELISTED
Bioverativ Inc. Common Stock
BIVV
-121,463
Closed -$6.93M
EXAC
1123
DELISTED
Exactech Inc
EXAC
-18,719
Closed -$617K
SCMP
1124
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
-26,670
Closed -$315K
CUDA
1125
DELISTED
Barracuda Networks, Inc.
CUDA
-30,500
Closed -$739K

Similar funds

Jacobs Levy Equity Management's Q4 2017 Portfolio in Review

As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.

  • Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
  • Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
  • Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
  • Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
  • Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
  • Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.